These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 9174107

  • 1. Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum.
    Yeo AE, Seymour KK, Rieckmann KH, Christopherson RI.
    Biochem Pharmacol; 1997 Apr 04; 53(7):943-50. PubMed ID: 9174107
    [Abstract] [Full Text] [Related]

  • 2. Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture.
    Yeo AE, Seymour KK, Rieckmann KH, Christopherson RI.
    Ann Trop Med Parasitol; 1997 Jan 04; 91(1):17-23. PubMed ID: 9093425
    [Abstract] [Full Text] [Related]

  • 3. The activity of triple combinations of antifolate biguanides, with and without folinic acid, against plasmodium falciparum in vitro.
    Yeo AE, Rieckmann KH.
    Ann Trop Med Parasitol; 1997 Apr 04; 91(3):247-51. PubMed ID: 9229018
    [Abstract] [Full Text] [Related]

  • 4. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
    Canfield CJ, Milhous WK, Ager AL, Rossan RN, Sweeney TR, Lewis NJ, Jacobus DP.
    Am J Trop Med Hyg; 1993 Jul 04; 49(1):121-6. PubMed ID: 8352384
    [Abstract] [Full Text] [Related]

  • 5. Antimalaria activity of the triple combination of proguanil, atovaquone and dapsone.
    Yeo AE, Edstein MD, Rieckmann KH.
    Acta Trop; 1997 Sep 30; 67(3):207-14. PubMed ID: 9241385
    [Abstract] [Full Text] [Related]

  • 6. Multiple synergistic interactions between atovaquone and antifolates against Plasmodium falciparum in vitro: a rational basis for combination therapy.
    Nduati EW, Kamau EM.
    Acta Trop; 2006 Mar 30; 97(3):357-63. PubMed ID: 16457769
    [Abstract] [Full Text] [Related]

  • 7. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
    Muehlen M, Schreiber J, Ehrhardt S, Otchwemah R, Jelinek T, Bienzle U, Mockenhaupt FP.
    Trop Med Int Health; 2004 Mar 30; 9(3):361-3. PubMed ID: 14996365
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
    Thapar MM, Gupta S, Spindler C, Wernsdorfer WH, Björkman A.
    Trans R Soc Trop Med Hyg; 2003 Mar 30; 97(3):331-7. PubMed ID: 15228254
    [Abstract] [Full Text] [Related]

  • 9. In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand.
    Edstein MD, Bahr S, Kotecka B, Shanks GD, Rieckmann KH.
    Antimicrob Agents Chemother; 1997 Oct 30; 41(10):2300-1. PubMed ID: 9333069
    [Abstract] [Full Text] [Related]

  • 10. Synergistic antimalarial activity of dapsone/dihydrofolate reductase inhibitors and the interaction of antifol, antipyrimidine and antipurine combinations against Plasmodium falciparum in vitro.
    Scott HV, Rieckmann KH, O'Sullivan WJ.
    Trans R Soc Trop Med Hyg; 1987 Oct 30; 81(5):715-21. PubMed ID: 3329779
    [Abstract] [Full Text] [Related]

  • 11. dCTP levels are maintained in Plasmodium falciparum subjected to pyrimidine deficiency or excess.
    Seymour KK, Yeo AE, Rieckmann KH, Christopherson RI.
    Ann Trop Med Parasitol; 1997 Sep 30; 91(6):603-9. PubMed ID: 9425362
    [Abstract] [Full Text] [Related]

  • 12. In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs.
    Winstanley PA, Mberu EK, Szwandt IS, Breckenridge AM, Watkins WM.
    Antimicrob Agents Chemother; 1995 Apr 30; 39(4):948-52. PubMed ID: 7786001
    [Abstract] [Full Text] [Related]

  • 13. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M, Gutteridge W, Zeman A, Dickins M, Woolley JL.
    J Travel Med; 1999 May 30; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [Abstract] [Full Text] [Related]

  • 14. A mechanism for the synergistic antimalarial action of atovaquone and proguanil.
    Srivastava IK, Vaidya AB.
    Antimicrob Agents Chemother; 1999 Jun 30; 43(6):1334-9. PubMed ID: 10348748
    [Abstract] [Full Text] [Related]

  • 15. Direct comparison of antimalarial activity among PS-15 combination therapies by bioassay of serum samples from treated Saimiri sciureus.
    Yeo AE.
    J Parasitol; 1997 Jun 30; 83(3):515-8. PubMed ID: 9194836
    [Abstract] [Full Text] [Related]

  • 16. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand.
    Wilairatana P, Kyle DE, Looareesuwan S, Chinwongprom K, Amradee S, White NJ, Watkins WM.
    Ann Trop Med Parasitol; 1997 Mar 30; 91(2):125-32. PubMed ID: 9307653
    [Abstract] [Full Text] [Related]

  • 17. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
    Fidock DA, Nomura T, Wellems TE.
    Mol Pharmacol; 1998 Dec 30; 54(6):1140-7. PubMed ID: 9855645
    [Abstract] [Full Text] [Related]

  • 18. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.
    Fivelman QL, Adagu IS, Warhurst DC.
    Antimicrob Agents Chemother; 2004 Nov 30; 48(11):4097-102. PubMed ID: 15504827
    [Abstract] [Full Text] [Related]

  • 19. Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates.
    Edstein MD, Yeo AE, Shanks GD, Rieckmann KH.
    Acta Trop; 1997 Sep 10; 66(3):127-35. PubMed ID: 9210963
    [Abstract] [Full Text] [Related]

  • 20. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K, Scott L.
    Drugs; 2003 Sep 10; 63(6):597-623. PubMed ID: 12656656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.